Vaš brskalnik ne omogoča JavaScript!
JavaScript je nujen za pravilno delovanje teh spletnih strani. Omogočite JavaScript ali pa uporabite sodobnejši brskalnik.
Nacionalni portal odprte znanosti
Odprta znanost
DiKUL
slv
|
eng
Iskanje
Brskanje
Novo v RUL
Kaj je RUL
V številkah
Pomoč
Prijava
Possible advantages of S53P4 bioactive glass in the treatment of septic osteoarthritis of the first metatarsophalangeal joint in the diabetic foot
ID
Kastrin, Matevž
(
Avtor
),
ID
Urbančič-Rovan, Vilma
(
Avtor
),
ID
Frangež, Igor
(
Avtor
)
PDF - Predstavitvena datoteka,
prenos
(1,56 MB)
MD5: F2A0D262F83FEE015B6E6CCF7282EDA9
URL - Izvorni URL, za dostop obiščite
https://www.mdpi.com/2077-0383/10/6/1208
Galerija slik
Izvleček
Biomechanically, the great toe with its metatarsophalangeal (MTP) joint plays a key role in standing and walking, making the first MTP joint one of the main predilection sites for ulcer formation, and consequently for bone and joint infection and even amputation. If conservative treatment fails, the main goal of surgery is to remove all infected tissue and preserve the first ray. To improve surgical outcomes, development of new biomaterials like Bioactive Glass S53P4 has begun. Bioactive Glass is useful because of its antibacterial properties; furthermore, its osteostimulative and osteoconductive qualities make the bone substitute particularly suitable as a bone defect filler for the treatment of osteomyelitis. The aim of our retrospective observational study was to compare the outcomes following ulcerectomy with segmental resection of the infected joint and bone and temporary stabilization with an external fixator, both with and without added Bioactive Glass. A comparison of added Bioactive Glass with the traditional surgical treatment in septic osteoarthritis of the first MTP joint showed Bioactive Glass to be effective. During a one-year follow-up, patients with Bioactive Glass required no additional antibiotic therapy or surgical intervention. Bioactive Glass, when applied to the diabetic foot, showed itself to be a safe bone substitute biomaterial.
Jezik:
Angleški jezik
Ključne besede:
septic osteoarthritis
,
diabetic foot
,
bioactive glass
,
foot ulcer
,
segmental resection of the first MTP joint
,
diabetic foot osteomyelitis
Vrsta gradiva:
Članek v reviji
Tipologija:
1.01 - Izvirni znanstveni članek
Organizacija:
MF - Medicinska fakulteta
Status publikacije:
Objavljeno
Različica publikacije:
Objavljena publikacija
Leto izida:
2021
Št. strani:
9 str.
Številčenje:
Vol. 10, iss. 6, art. 1208
PID:
20.500.12556/RUL-135215
UDK:
616.379
ISSN pri članku:
2077-0383
DOI:
10.3390/jcm10061208
COBISS.SI-ID:
55827971
Datum objave v RUL:
01.03.2022
Število ogledov:
703
Število prenosov:
110
Metapodatki:
Citiraj gradivo
Navadno besedilo
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Kopiraj citat
Objavi na:
Gradivo je del revije
Naslov:
Journal of clinical medicine
Skrajšan naslov:
J. clin. med.
Založnik:
MDPI
ISSN:
2077-0383
COBISS.SI-ID:
5405759
Licence
Licenca:
CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:
http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:
To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.
Začetek licenciranja:
15.03.2021
Podobna dela
Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:
Nazaj